- MDMB-4en-PICA
- Methyl (S)-3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indole-3-carboxamido)butanoate
- Methyl (2S)-3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indol-3-yl]formamido}butanoate
Cannaert, A; Sparkes, E; Pike, E; Luo, JL; Fang, A; Kevin, RC; Ellison, R; Gerona, R; Banister, SD; Stove, CP. Synthesis and in vitro cannabinoid receptor 1 activity of recently detected synthetic cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA ACS Chem. Neurosci., 16 Dec 2020, 11 (24), 4434–4446. 3.7 MB. https://doi.org/10.1021/acschemneuro.0c00644 #4a MS,NMR,IR,TLC
Grafinger, KE; Vandeputte, MM; Cannaert, A; Ametovski, A; Sparkes, E; Cairns, E; Juchli, PO; Haschimi, B; Pulver, B; Banister, SD; Stove, CP; Auwärter, V. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays Drug Test. Anal., 21 May 2021, 13 (7), 1412-1429. 4.3 MB. https://doi.org/10.1002/dta.3054 #2